Features

Latest Features

Skin Cancer

How Do Melanoma Comorbidities Affect Patient Treatment Preferences?

By

Steve Fiorillo

Observational study design and conflicts of interest prevent researchers from determining whether the FDA-mandated black box warning is warranted.

Skin Cancer

Industry-Funded Study Suggests There Is No Association Between TCI Use and Increased Skin Cancer Risk in Atopic Dermatitis

By

Agata Boxe

Patients given prophylactic treatment were 94% less likely to require a first rescue treatment for rash and 74% less likely to require a second rescue treatment.

Skin Cancer

Skin Toxicity Program Can Positively Address EGFR Inhibitor-Related Skin Toxicities

By

Leah Lawrence

COVID doctor prescribing

Infections

Dermatologic Challenges to Preventing Antimicrobial Resistance During the COVID-19 Pandemic

By

Linda Peckel

General Dermatology

The Appearance of Skin Disorders Often Predicts Diabetes

By

Linda Peckel

Practice Management

Seven Tips for Managing Healthcare Teamwork During a Pandemic

By

Batya Swift Yasgur, MA, LSW

3-D skin bioprinting

Skin Injury

3-D Skin Bioprinting: The Future for Wound Healing?

By

Tori Rodriguez, MA, LPC, AHC

T cells attacking cancer cells

Skin Cancer

Melanoma Risk and Biologic Therapy: Is There a Link?

By

C. Andrew Kistler, MD, PharmD

Doctor apologizing to couple in the waiting room

Practice Management

Apologies, Properly Made, Go Far in Maintaining Physician-Patient Relationship

By

David J. Alfandre, MD, MSPH

tasting ice cream woman

General Dermatology

Is It COVID-19 or Is It Your Meds?

By

Heidi W. Moore